GetTopicDetailResponse(id=ab6b19130b3, topicName=α-受體阻滯劑, introduction=α-受體阻滯劑, content=null, image=null, comments=1, allHits=1768, url=https://h5.medsci.cn/topic?id=19130, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=31117, tagList=[TagDto(tagId=31117, tagName=α-受體阻滯劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2144640, encodeId=dc8c2144640f5, content=<a href='/topic/show?id=1c1710265113' target=_blank style='color:#2F92EE;'>#高血壓#</a><a href='/topic/show?id=74e818333c' target=_blank style='color:#2F92EE;'>#ACEI#</a>、<a href='/topic/show?id=c24e2e2076' target=_blank style='color:#2F92EE;'>#ARB#</a>和<a href='/topic/show?id=577b4195fe' target=_blank style='color:#2F92EE;'>#CCB#</a>都能降低主要<a href='/topic/show?id=38c451e4317' target=_blank style='color:#2F92EE;'>#心血管事件#</a>的風(fēng)險(xiǎn)。<a href='/topic/show?id=573332291bd' target=_blank style='color:#2F92EE;'>#利尿劑#</a>表現(xiàn)出類似的趨勢(shì)，而β-受體阻滯劑和腎素抑制劑則沒(méi)有。就依從性而言，ARB和CCB與安慰劑相當(dāng)，而ACEI、<a href='/topic/show?id=6ebe1918eb0' target=_blank style='color:#2F92EE;'>#β-受體阻滯劑#</a>和<a href='/topic/show?id=ab6b19130b3' target=_blank style='color:#2F92EE;'>#α-受體阻滯劑#</a>與安慰劑和其他藥物相比明顯更容易出現(xiàn)中止治療。, objectTitle=ESH 2023 重磅開(kāi)啟 | 一文盡覽！多項(xiàng)高血壓重磅研究結(jié)果公布！, objectType=article, longId=778450, objectId=d670e784505c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230619/50a9c31b1fcd4b97bc867ef7fe6e7093.jpg, objectUrl=/article/show_article.do?id=d670e784505c, replyNumber=1, likeNumber=212, createdTime=2023-06-25, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d670e784505c, moduleTitle=ESH 2023 重磅開(kāi)啟 | 一文盡覽！多項(xiàng)高血壓重磅研究結(jié)果公布！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d670e784505c)], followStatus=false, userIsMember=false, type=1, lengthMark=1)]
梅斯話題小助手
2020-05-29
